AventaMed develops novel medical devices which streamline surgery, allowing procedures to move out of the Operating Room and into new sites of service, such as the doctor’s office or clinic.
AventaMed was crowned Seedcorn’s Overall Winner for the Best Early Stage Company in 2014 and Emerging Medtech Company of the Year, Irish Medical Device Association (IMDA) in 2015. The AventaMed team have successfully completed clinical studies, gained ISO 13485 certification, and obtained CE Mark for the Solo+™ device in Europe. We are now focused on European commercialisation and gaining FDA clearance for Solo+™.
Contact us for more information.
In 2023 AventaMed was acquired by KARL STORZ, a renowned global manufacturer and distributor of endoscopes, medical instruments, and devices. This partnership has solidified AventaMed's position in the industry and has opened up new possibilities for further innovation and advancement.
Keith has more than 30 years of medical device experience in global healthcare sales, marketing, and general management. Keith began his medical device career at Boston Scientific (13 years) where he held multiple leadership roles with progressive responsibilities. Keith has extensive start-up and general management experience gained from serving on the senior management team of Cortek (exit to AlphaTec Spine), President and CEO at InaVein, LLC (exit to LeMaitre Vascular) and President and CEO of Vascular Insights. Most recently, Keith was the Senior Vice President, International, for the American Heart Association. Keith holds a bachelor’s degree from Bucknell University, Lewisburg, PA as well as a graduate diploma in Entrepreneurial Management from Boston University.
John has over 18 years of experience in the medical device industry and has worked for numerous large medical device companies such as Stryker and Guidant. He is most experienced in medical device product development, strategic regulatory planning, regulatory approval, IP development and product realization. He has invented, designed, and commercially launched numerous products worldwide and he is the inventor on multiple granted and pending patents. John co-founded AventaMed in 2013 and has brought the Solo+™ tympanostomy tube device from an initial concept to commercial use. He has been instrumental in the leadership of the Company from its early formation to its acquisition by KARL STORZ in early 2023.
Carol is a Product Designer and Quality Engineer with over 10 years industry experience. She graduated from Dublin Institute of Technology with a first-class honors degree. Within her various roles, she has patented several products in Europe and the United States. She has designed products that range from automotive to medical devices and has helped lead those products from concept to commercialization. She’s had valuable experience in several different areas from EMC & thermal mitigation to catheters. Throughout all her roles she has gained great knowledge in Quality Systems, successfully leading numerous quality and microbiology audits.
With a background in biomedical engineering, Laura has experience in medical device research, development, clinical investigations, and regulatory approvals. She has knowledge and experience of medical device quality standards and regulations including FDA CFR, ISO 13485, EU MDR, ICH GCP and ISO 14155. She has been instrumental in helping to maintain our CE mark and leading clinical and regulatory affairs matters to expand our commercial footprint. Laura received her BEng and PhD degrees in Biomedical Engineering.
With a B.Sc. (Honors) degree in Biological and Biomedical Sciences from The National University of Ireland, Maynooth, Barbara has valuable knowledge and experience in clinical investigations, clinical validation, quality assurance and regulatory affairs. She is experienced in the regulatory approval process for medical devices and supporting the launch of new products on the market and in the life cycle management of on market medical devices.
Helen is a quality assurance professional with over 15 years industry experience in both medical device and pharmaceuticals. She graduated from the University of Glamorgan (University of South Wales) with an honour’s degree in Forensic Science. She is Lead Auditor trained. Helen has extensive experience with GMP quality systems including change management, CAPA and audit management. Helen maintains the AventaMed quality system and focuses on continuous improvements.
Sofia has over 20 years’ experience in the medical device industry. Her areas of expertise include marketing, business planning, market development and sales management at an international level. With a background in biotechnology engineering and additional education in digital marketing, Sofia’s medical device experience started at Johnson & Johnson Medical in Portugal. Her responsibilities rapidly grew with the Company while focusing on several different international markets: UK, Sub-Saharan Africa, and Middle East. More recently, Sofia was an ENT consultant for start-ups and multinational corporations.
Michael has extensive experience in the medical field. He has excelled in various roles, including senior management, sales, professional education while demonstrating exceptional leadership and achieving outstanding results. Having served as a medic in the Royal Air Force, Michael developed a solid foundation in medicine and honed his skills in managing teams and handling critical situations. His success spans both large corporations and start-up companies with a particular focus and expertise in ear, nose, and throat (ENT) medicine.
AventaMed’s clinical advisors are world renowned otolaryngologists with a special interest in otitis media. Our dedicated Clinical Advisors are experts in Otology and have strong connections to medical associations around the world.
Dr. Joseph Kerschner serves as Provost, Executive Vice President and The Julia A. Uihlein, MA. Dean of the School of Medicine at the Medical College of Wisconsin (MCW). He became the Dean of the School of Medicine and Executive Vice President in November 2011 following 10 months as Interim Dean. Dr. Kerschner assumed the additional role of Provost of the MCW Health Science University in 2017. He is a Professor in the Departments of Otolaryngology and Communication Sciences and Microbiology and Immunology.
Dr. Kerschner maintains an active research laboratory which has been continuously funded by the National Institutes of Health since 2001. He is an engaged leader in medicine and has held numerous leadership roles, including serving as Chair of the Council of Deans for the Association of American Medical Colleges (AAMC) and Chair of the AAMC’s Board of Directors. Dr. Kerschner maintains an active membership on numerous professional and honorary societies and has held critical leadership roles in otolaryngology including President of the American Society of Pediatric Otolaryngology (ASPO), President of the International Society for Otitis Media (ISOM), Editor-in-Chief for the International Journal of Pediatric Otorhinolaryngology and Senior Examiner for the American Board of Otolaryngology.
Prof. Narula was a consultant otorhinolaryngologist at St Mary’s Hospital, Paddington, Charing Cross Hospital and Hammersmith Hospital. He was also an Honorary Consultant at Chelsea & Westminster and Royal Brompton Hospitals and took early retirement in December 2014. He has a special interest in children with ear, nose and throat disorders and hearing problems. He was elected the President of the British Society of Otology 2010 – 2012. He was awarded an Honorary Professorship from Middlesex Hospital in 2003 and has been national clinical lead for ENT for the NHS Modernisation Agency, winning a Beacon award in 1999 for waiting list management and innovation.
He has an interest in medical politics and served as President of both the Association of Otolaryngologists in Training and the Young Consultant Otolaryngologists. He was editor of the CME Bulletin Otolaryngology and instigated a diploma course for GPs to learn more about Otolaryngology (DepENT). He was elected to the Council of the Royal College of Surgeons in 2004 where he was the Honorary Treasurer and served as President of ENT UK from 2015-2017. Prof. Narula took early retirement from his Government practice and continues in private practice where he’s also a Clinical Advisor to Audelation, Ltd. as well as a Clinical ENT Advisor to Ufonia, Ltd.
Dr. Mat Daniel is a Consultant Paediatric Otorhinolaryngologist in Nottingham, UK. He trained in the East Midlands and in Sydney and obtained a PhD in the fields of Glue Ear microbiology / biofilms and drug delivery. He has a master’s degree in Coaching, a master’s degree in Medical Education, and is the undergraduate lead for ENT at The University of Nottingham. He is involved in a variety of research projects including clinical trials.